ARTICLE | Company News
Genzyme General, Genzyme Molecular deal
January 7, 2002 8:00 AM UTC
GZMO transferred its cancer diagnostics IP to GENZ's Genzyme Genetics business unit. Genzyme Genetics will have rights to cancer markers and cancer-related genes for use in diagnostic development and ...